An article on Xeltis’ clinical development is featured in Cardiology Today.
“(The) “self-healing” proprietary biodegradable polymer also has the potential to change the practice of cardiac and vascular surgeries, which hundreds of thousands of patients undergo every year.”
For the full article, click here.
